Cost-effectiveness of screening for HLA - A *31:01 prior to initiation of carbamazepine in epilepsy (2015)

First Author: Plumpton C

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/epi.12937

PubMed Identifier: 26046144

Publication URI: http://europepmc.org/abstract/MED/26046144

Type: Journal Article/Review

Parent Publication: Epilepsia

Issue: 4

ISSN: 0013-9580